Group | Subgroup | No. (%) | No. (%) | |
Eczematous diseases | 463 (27.2) | Atopic dermatitis | 152 (8.9) | |
Unspecify dermatitis (non-atopic dermatitis) | 311 (18.3) | |||
Urticaria/anaphylaxis | 478 (28.1) | Urticaria | 395 (23.2) | |
Anaphylaxis | 83 (4.9) | |||
Drug eruptions | 64 (3.7) | SJS/TEN | 3 (0.2) | |
Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome | 3 (0.2) | |||
Maculopapular drug exanthem | 50 (2.9) | |||
Other drug eruptions | 8 (0.5) | |||
Infections | Infectious exanthem | 390 (22.9) | Unspecified infectious exanthem | 390 (22.9) |
Viral infections | 155 (9.1) | Varicella infection (chicken pox) | 38 (2.2) | |
Herpes infection | 40 (2.4) | |||
Herpes zoster infection | 19 (1.1) | |||
Molluscum contagiosum | 5 (0.3) | |||
Warts | 6 (0.4) | |||
Measles | 11 (0.6) | |||
Infectious mononucleosis with skin lesions | 21 (1.2) | |||
Dengue infection with skin lesions | 15 (0.9) | |||
Bacterial infections | 69 (4.2) | Staphylococcal scald skin syndrome | 5 (0.3) | |
Sepsis with skin lesions | 2 (0.1) | |||
Scarlet fever | 12 (0.7) | |||
Impetigo | 29 (1.7) | |||
Cellulitis | 9 (0.5) | |||
Abscess | 10 (0.6) | |||
Necrotising fasciitis | 2 (0.1) | |||
Other infections | 32 (1.9) | Pityriasis versicolor | 14 (0.8) | |
Dermatophyte infections | 10 (0.6) | |||
Candida infections | 6 (0.4) | |||
Parasites (scabies, enterobius vermicularis) | 2 (0.1) | |||
Miscellaneous | 49 (2.9) | Acne | 9 (0.5) | |
Millia, miliria rubra, milliaria crystallena | 4 (0.2) | |||
Collagen vascular diseases (SLE, dermatomyositis) | 11 (0.6) | |||
Papulosquamous diseases (psoriasis, pityriasis rubra pilaris, pityriasis lichenoides) | 12 (0.7) | |||
Other inconclusive diagnosis | 13 (0.8) | |||
Total | 1701 (100) |
SJS, Steven-Johnsons syndrome; SLE, systemic lupus erythematosus; TEN, toxic epidermal necrolysis.